TY - JOUR
T1 - How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19
AU - Accorsi, Emma K
AU - Qiu, Xueting
AU - Rumpler, Eva
AU - Kennedy-Shaffer, Lee
AU - Kahn, Rebecca
AU - Joshi, Keya
AU - Goldstein, Edward
AU - Stensrud, Mats J
AU - Niehus, Rene
AU - Cevik, Muge
AU - Lipsitch, Marc
N1 - Funding: National Institute of Allergy and Infectious Diseases of the National Institutes of Health (award number T32AI007535), the National Institute of General Medical Sciences of the National Institutes of Health (award number U54GM088558), the Morris-Singer Fund, and the National Institutes of Health (cooperative agreement U01 CA261277).
PY - 2021/2/25
Y1 - 2021/2/25
N2 - In response to the coronavirus disease (COVID-19) pandemic, public health scientists have produced a large and rapidly expanding body of literature that aims to answer critical questions, such as the proportion of the population in a geographic area that has been infected; the transmissibility of the virus and factors associated with high infectiousness or susceptibility to infection; which groups are the most at risk of infection, morbidity and mortality; and the degree to which antibodies confer protection to re-infection. Observational studies are subject to a number of different biases, including confounding, selection bias, and measurement error, that may threaten their validity or influence the interpretation of their results. To assist in the critical evaluation of a vast body of literature and contribute to future study design, we outline and propose solutions to biases that can occur across different categories of observational studies of COVID-19. We consider potential biases that could occur in five categories of studies: (1) cross-sectional seroprevalence, (2) longitudinal seroprotection, (3) risk factor studies to inform interventions, (4) studies to estimate the secondary attack rate, and (5) studies that use secondary attack rates to make inferences about infectiousness and susceptibility.
AB - In response to the coronavirus disease (COVID-19) pandemic, public health scientists have produced a large and rapidly expanding body of literature that aims to answer critical questions, such as the proportion of the population in a geographic area that has been infected; the transmissibility of the virus and factors associated with high infectiousness or susceptibility to infection; which groups are the most at risk of infection, morbidity and mortality; and the degree to which antibodies confer protection to re-infection. Observational studies are subject to a number of different biases, including confounding, selection bias, and measurement error, that may threaten their validity or influence the interpretation of their results. To assist in the critical evaluation of a vast body of literature and contribute to future study design, we outline and propose solutions to biases that can occur across different categories of observational studies of COVID-19. We consider potential biases that could occur in five categories of studies: (1) cross-sectional seroprevalence, (2) longitudinal seroprotection, (3) risk factor studies to inform interventions, (4) studies to estimate the secondary attack rate, and (5) studies that use secondary attack rates to make inferences about infectiousness and susceptibility.
KW - COVID-19
KW - Epidemiological biases
KW - Measurement error
KW - Misclassification
KW - Observational data
KW - Selection bias
U2 - 10.1007/s10654-021-00727-7
DO - 10.1007/s10654-021-00727-7
M3 - Review article
C2 - 33634345
SN - 0393-2990
JO - European Journal of Epidemiology
JF - European Journal of Epidemiology
ER -